Clinical Trial Update: Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the ProxiScan transrectal scintigraphic detector for detection of primary prostate cancer. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Suspected Primary Prostate Cancer | Phase 1 | Status: COMPLETED